Shares of the pharmacy chain plummeted 25% after The Wall Street Journal reported the CEO’s plans and the company lowered its guidance for the full year.
![](https://immunet.online/wp-content/uploads/2024/06/medium-tCTDa8.jpeg)
Shares of the pharmacy chain plummeted 25% after The Wall Street Journal reported the CEO’s plans and the company lowered its guidance for the full year.